1. Home
  2. RPD vs INMD Comparison

RPD vs INMD Comparison

Compare RPD & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rapid7 Inc.

RPD

Rapid7 Inc.

HOLD

Current Price

$10.40

Market Cap

746.5M

Sector

Technology

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$14.92

Market Cap

854.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPD
INMD
Founded
2000
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
746.5M
854.5M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
RPD
INMD
Price
$10.40
$14.92
Analyst Decision
Hold
Hold
Analyst Count
23
5
Target Price
$15.05
$17.33
AVG Volume (30 Days)
1.7M
410.4K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$685,083,000.00
N/A
Revenue This Year
N/A
$1.74
Revenue Next Year
$0.54
$3.26
P/E Ratio
$96.00
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$4.97
$12.72
52 Week High
$20.95
$16.74

Technical Indicators

Market Signals
Indicator
RPD
INMD
Relative Strength Index (RSI) 42.20 39.86
Support Level $6.24 $13.27
Resistance Level $13.79 $15.24
Average True Range (ATR) 0.72 0.19
MACD -0.33 -0.03
Stochastic Oscillator 8.54 20.83

Price Performance

Historical Comparison
RPD
INMD

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: